companydata.dkcompanydata.dk

Asahi Kasei Pharma Denmark A/S: Financial statements 2024

CVR: 40948074

Source: annual report 2024, Danish Business Authority

01/04/2023 – 31/03/2024

Asahi Kasei Pharma Denmark A/S (CVR 40948074) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -757,973 and a net result of DKK 25,492,949 compared with DKK 18,232,738 the year before. Equity in the 2024 report amounted to DKK 951,385,568. The solvency ratio was 99.4%.

Gross Profit
DKK -757,973
Profit/Loss
DKK 25,492,949
Equity
DKK 951,385,568
Total Assets
DKK 957,054,116
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--758K25.5M951.4M0
2023--941K18.2M925.9M0
2022--1.2M4.7M907.7M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

About Asahi Kasei Pharma Denmark A/S

Asahi Kasei Pharma Denmark A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named River Forest A/S. The management consists of Daisuke Matsuo. The board consists of Masaya Etoh (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -793,488 and a net result of DKK 25,833,192 compared with DKK 26,072,771 the year before. Equity in the 2026 report amounted to DKK 1,003,291,531.

Source: annual report 2026, Danish Business Authority

Other financial years